TL;DR: Evolvere BioSciences is a Y Combinator Summer 2024 startup Making Next-Generation Antibiotics that Outpace Bacterial Evolution, currently active with a team of 3.
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
Last verified:
🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat pati…
Built by LemStudio
Yes. Evolvere BioSciences was funded by Y Combinator in the Summer 2024 batch. Making Next-Generation Antibiotics that Outpace Bacterial Evolution
🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a loomi…
Evolvere BioSciences was part of Y Combinator's Summer 2024 batch.
Evolvere BioSciences has a team of 3 people according to Y Combinator's directory.
Evolvere BioSciences is currently listed as Active with a team of 3 in Y Combinator's directory.
Loading interactive view…